Jonathan P Singer

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94117, USA
    Med Clin North Am 96:767-87. 2012
  2. ncbi Survival following lung transplantation for silicosis and other occupational lung diseases
    J P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA
    Occup Med (Lond) 62:134-7. 2012
  3. ncbi The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans
    Jonathan P Singer
    Division of Pulmonary Critical Care Medicine, UC San Francisco, CA 94143, USA
    J Intensive Care Med 25:233-9. 2010
  4. ncbi Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Heart Lung Transplant 29:1009-13. 2010
  5. ncbi Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function
    Jonathan Singer
    Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California 94143, USA
    J Cardiopulm Rehabil Prev 31:111-9. 2011
  6. ncbi The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation
    J P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, USA
    Am J Transplant 11:2197-204. 2011
  7. ncbi The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients
    Christopher Metchnikoff
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94115, USA
    J Am Acad Dermatol 67:829-35. 2012
  8. ncbi Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, Calif, USA
    Respiration 85:375-83. 2013
  9. ncbi Use of sublingual tacrolimus in lung transplant recipients
    Katherine D Watkins
    Department of Clinical Pharmacy, University of California, San Francisco, California 94143 0622, USA
    J Heart Lung Transplant 31:127-32. 2012
  10. ncbi High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, University of California at San Francisco, San Francisco, California 94115, USA
    J Heart Lung Transplant 31:694-9. 2012

Detail Information

Publications13

  1. ncbi Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94117, USA
    Med Clin North Am 96:767-87. 2012
    ..Future research will provide a better understanding of the effects of COPD on HRQOL and the impact of various interventions...
  2. ncbi Survival following lung transplantation for silicosis and other occupational lung diseases
    J P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA
    Occup Med (Lond) 62:134-7. 2012
    ..Information is scant assessing outcomes in lung transplantation (LT) in advanced occupational lung diseases (OLD)...
  3. ncbi The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans
    Jonathan P Singer
    Division of Pulmonary Critical Care Medicine, UC San Francisco, CA 94143, USA
    J Intensive Care Med 25:233-9. 2010
    ....
  4. ncbi Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Heart Lung Transplant 29:1009-13. 2010
    ..Having identified a high incidence of supratherapeutic anti-factor Xa levels in lung transplant recipients, we aimed to elucidate the relationship between enoxaparin dose and anti-factor Xa level in this patient population...
  5. ncbi Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function
    Jonathan Singer
    Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California 94143, USA
    J Cardiopulm Rehabil Prev 31:111-9. 2011
    ..We sought to quantify the impact of respiratory muscle and lower extremity strength on exercise capacity and lower extremity function (LEF) in patients with chronic obstructive pulmonary disease (COPD)...
  6. ncbi The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation
    J P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, USA
    Am J Transplant 11:2197-204. 2011
    ..Notably, the increased risk of death appears to be strongest the early posttransplant period and limited to certain pretransplant diagnoses...
  7. ncbi The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients
    Christopher Metchnikoff
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94115, USA
    J Am Acad Dermatol 67:829-35. 2012
    ..The newly updated 7th edition American Joint Committee on Cancer (AJCC) staging system for cSCC is based on consensus expert opinion and requires validation in large cohort studies and in specific patient subpopulations...
  8. ncbi Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, Calif, USA
    Respiration 85:375-83. 2013
    ..5-times higher than the rate observed in obligatory activities (p < 0.05 for each level). Conclusions: Disability is common in COPD. Both pulmonary and extra-pulmonary factors are important in predicting its development...
  9. ncbi Use of sublingual tacrolimus in lung transplant recipients
    Katherine D Watkins
    Department of Clinical Pharmacy, University of California, San Francisco, California 94143 0622, USA
    J Heart Lung Transplant 31:127-32. 2012
    ..We aimed to identify a dose conversion ratio between oral and sublingual tacrolimus in LTRs...
  10. ncbi High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, University of California at San Francisco, San Francisco, California 94115, USA
    J Heart Lung Transplant 31:694-9. 2012
    ..Voriconazole, which is associated with phototoxic side effects in some patients, may be an additional risk factor for SCC in this population...
  11. ncbi Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD
    Moshe Zutler
    Department of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, California 94143, USA
    Prim Care Respir J 21:194-201. 2012
    ..Obesity contributes to respiratory symptoms and exercise limitation, but the relationships between obesity, airflow obstruction (AO), respiratory symptoms and functional limitation are complex...
  12. ncbi Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection
    David M Sayah
    Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Clin Transplant 27:E64-71. 2013
    ..Community acquired respiratory virus (CARV) infections in lung transplant recipients (LTR) have been associated with adverse outcomes, including acute rejection (AR) and decline in allograft function, in some but not in all studies...
  13. ncbi An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients
    Leah Smith
    Department of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco, CA 94143 0903, USA
    Transpl Int 25:172-8. 2012
    ..30). The involvement of trainees, pre-transplant diagnosis, and transplant type do not significantly impact the rate of bronchoscopic complications in lung transplant recipients...